The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7% according to a new report by MarketsandMarkets™. The growth of this market is mainly driven by increasing transplant procedures, advances in HLA-type technologies, increasing public and private funding for targeted research activities, and increasing burden on infectious diseases driving the growth of HLA.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742
Browse in-depth TOC on “HLA Typing for Transplant Market”
141 – Tables
36 – Figures
193 – Pages
Based on the product, the reagents & consumables segment held the largest share of the market.
Based on the product, the HLA typing for the transplants market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global HLA typing for the transplants market
Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.
Based on technology, the HLA typing for the transplants market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period.
Based on the application, the diagnostic application segment accounted for the largest share of this market.
Based on the application, the HLA typing for the transplants market is categorized into diagnostic and research applications. Diagnostic applications accounted for the largest share of the HLA typing for the transplants market
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742
North America accounted for the largest share of the HLA typing for transplants market
North America accounted for the largest share of the HLA typing for the transplants market, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products (includes HLA typing) coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.
Some of the prominent players in the HLA typing for the transplants market are Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Netherlands), Illumina (US), CareDx, Inc. (US), and Immucor, Inc. (US). Others are Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Luminex (US), Biofortuna (UK), Takara Bio (Japan), Omixon (Hungary), Becton, Dickinson and Company (US), Fujirebio, Inc. (Japan), and TBG Diagnostics Ltd. (Australia)
Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.